Cross Species Single Domain Antibodies Targeting PD-L1 For Treating Solid Tumors Read more about Cross Species Single Domain Antibodies Targeting PD-L1 For Treating Solid Tumors US Application 18/567,990Filed on 2023-12-07
Cross Species Single Domain Antibodies Targeting PD-L1 For Treating Solid Tumors Read more about Cross Species Single Domain Antibodies Targeting PD-L1 For Treating Solid Tumors China2022800415318Filed on 2023-12-08
Cross Species Single Domain Antibodies Targeting PD-L1 For Treating Solid Tumors Read more about Cross Species Single Domain Antibodies Targeting PD-L1 For Treating Solid Tumors Australia2022291120Filed on 2023-11-01
Cross Species Single Domain Antibodies Targeting PD-L1 For Treating Solid Tumors Read more about Cross Species Single Domain Antibodies Targeting PD-L1 For Treating Solid Tumors Canada3216228Filed on 2023-10-04
T CELL RECEPTORS TARGETING MUTATED CDKN2A Read more about T CELL RECEPTORS TARGETING MUTATED CDKN2A Patent Cooperation TreatyPCT/US2023/078190Filed on 2023-10-30
METHODS FOR SELECTIVELY EXPANDING CELLS EXPRESSING A TCR WITH A MURINE CONSTANT REGION Read more about METHODS FOR SELECTIVELY EXPANDING CELLS EXPRESSING A TCR WITH A MURINE CONSTANT REGION Singapore10202302822QFiled on 2023-10-03
METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A P53 CANCER-SPECIFIC MUTATION Read more about METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A P53 CANCER-SPECIFIC MUTATION Singapore10202302739VFiled on 2023-09-27
ANTI-KRAS-G12D T CELL RECEPTORS Read more about ANTI-KRAS-G12D T CELL RECEPTORS Australia2023233125Filed on 2023-09-21
HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH Q61K MUTATION Read more about HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH Q61K MUTATION European Patent22721599.3Filed on 2023-11-20
HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH Q61K MUTATION Read more about HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH Q61K MUTATION US Application 18/286,911Filed on 2023-10-13